Specjalistyczna Praktyka Lekarska Gravita
Lodz, Poland
Obstetrician-gynecologist in Łódź
Gen. Karola Kniaziewicza 20a/20, 91-347 Łódź
About Specjalistyczna Praktyka Lekarska Gravita
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
BioNTech SE
1
Clinical Trials at Specjalistyczna Praktyka Lekarska Gravita
During the past decade, Specjalistyczna Praktyka Lekarska Gravita conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.
2011-03-18
2013-02-19
Completed
753
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®
2011-08-01
2013-01-01
Completed
908
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
2015-08-31
2020-03-17
Completed
396
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants
2020-09-09
2023-02-18
Completed
1,258
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults
2021-03-24
2024-10-03
Active, not recruiting
11,109
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
2021-04-09
2022-09-09
Completed
149
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Specjalistyczna Praktyka Lekarska Gravita"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Specjalistyczna Praktyka Lekarska Gravita
According to Clinical.Site data, the most researched conditions in "Specjalistyczna Praktyka Lekarska Gravita" are
"Meningococcal Vaccine" (2 trials), "Meningitis" (1 trials), "Meningococcal B Disease" (1 trials), "N Meningitidis Serogroup B" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Specjalistyczna Praktyka Lekarska Gravita" in a lesser frequency.
Clinical Trials Intervention Types at Specjalistyczna Praktyka Lekarska Gravita
Most popular intervention types in "Specjalistyczna Praktyka Lekarska Gravita" are "Biological" (6 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (2 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "BNT162b2 20mcg" (1 trials), "BNT162b2 30mcg" (1 trials) and "Biological/Vaccine: BNT162b2 10mcg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Specjalistyczna Praktyka Lekarska Gravita
The vast majority of trials in "Specjalistyczna Praktyka Lekarska Gravita" are
6 trials for "All" genders.
Clinical Trials Status at Specjalistyczna Praktyka Lekarska Gravita
Currently, there are NaN active trials in "Specjalistyczna Praktyka Lekarska Gravita".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Specjalistyczna Praktyka Lekarska Gravita,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Specjalistyczna Praktyka Lekarska Gravita, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".